Recent Company News

• 04:53 PM ET Dec 03, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 09:17 AM ET Nov 12, 2025
  

  StreetAccount Summary - US Pre-market trading update

• 08:53 AM ET Dec 03, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 11:53 AM ET Dec 02, 2025
  

  StreetAccount Summary - US unusual volume traders

• 06:49 AM ET Dec 01, 2025
  

  StreetAccount Summary - European unusual volume traders

• 08:07 AM ET Nov 12, 2025
  

  CORRECTION: DBV Technologies plans for VITESSE Phase 3 data readout in 4-7 year olds by end of 2025 ($13.34, 0.00)

• 03:51 AM ET Nov 12, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 12:00 AM ET Nov 12, 2025
  

  Last patient visit completed in VITESSE trial of DBV Technologies's VIASKIN Peanut patch in peanut allergic children aged 4-7 years (€2.43, 0.00)

• 02:42 PM ET Nov 11, 2025
  

  Transcript Intelligence: DBV Technologies at Guggenheim Healthcare Innovation Conference (€2.43, 0.00)